213,373 Shares in CVS Health Corporation $CVS Acquired by Varma Mutual Pension Insurance Co

Varma Mutual Pension Insurance Co bought a new stake in shares of CVS Health Corporation (NYSE:CVS) in the 2nd quarter, HoldingsChannel reports. The firm bought 213,373 shares of the pharmacy operator’s stock, valued at approximately $22,073,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Handelsbanken Fonder AB grew its holdings in shares of CVS Health by 83.6% in the 2nd quarter. Handelsbanken Fonder AB now owns 1,089,694 shares of the pharmacy operator’s stock worth $112,729,000 after acquiring an additional 496,124 shares during the last quarter. State Street Corp lifted its holdings in shares of CVS Health by 2.1% during the fourth quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock valued at $4,776,182,000 after purchasing an additional 1,245,457 shares during the last quarter. Legal & General Group Plc boosted its position in shares of CVS Health by 0.3% in the 4th quarter. Legal & General Group Plc now owns 9,309,182 shares of the pharmacy operator’s stock valued at $738,777,000 after purchasing an additional 31,249 shares during the period. Deutsche Bank AG increased its stake in CVS Health by 28.4% in the 4th quarter. Deutsche Bank AG now owns 4,666,495 shares of the pharmacy operator’s stock worth $370,333,000 after purchasing an additional 1,031,998 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. purchased a new position in CVS Health in the 2nd quarter worth about $49,622,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on CVS. Robert W. Baird set a $107.00 price objective on shares of CVS Health in a research note on Thursday, August 6th. Argus lifted their target price on shares of CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a research report on Wednesday. Royal Bank Of Canada boosted their price target on shares of CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a report on Thursday, July 9th. UBS Group raised their price objective on shares of CVS Health from $122.00 to $126.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of CVS Health from $88.00 to $92.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Twenty-two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $107.17.

CVS Health Trading Down 0.7%

Shares of NYSE CVS opened at $93.01 on Friday. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The business has a 50-day moving average price of $102.02 and a two-hundred day moving average price of $88.86. The firm has a market capitalization of $118.96 billion, a PE ratio of 24.61, a PEG ratio of 0.85 and a beta of 0.61.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. The company had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The firm’s quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, analysts predict that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 2.9%. The ex-dividend date was Thursday, July 23rd. CVS Health’s dividend payout ratio is currently 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.